GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) has earned a consensus rating of "Hold" from the twelve research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $128.80.
GRAL has been the subject of several recent research reports. Guggenheim increased their price target on GRAIL from $75.00 to $155.00 and gave the company a "buy" rating in a report on Thursday, October 1st. Canaccord Genuity Group increased their price objective on shares of GRAIL from $80.00 to $150.00 and gave the company a "buy" rating in a research note on Monday, September 28th. Piper Sandler raised their price objective on shares of GRAIL from $74.00 to $130.00 and gave the stock a "neutral" rating in a report on Tuesday, November 10th. Morgan Stanley upped their target price on shares of GRAIL from $60.00 to $120.00 and gave the company an "equal weight" rating in a research note on Monday, October 12th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of GRAIL in a research note on Thursday, October 15th.
Get Our Latest Analysis on GRAIL
GRAIL Stock Down 5.5%
Shares of GRAL stock opened at $99.11 on Friday. The business has a 50-day simple moving average of $123.99 and a 200-day simple moving average of $79.76. The stock has a market cap of $4.46 billion, a PE ratio of -10.43 and a beta of 2.86. GRAIL has a 52-week low of $41.50 and a 52-week high of $166.48.
GRAIL (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported ($2.21) earnings per share for the quarter, beating analysts' consensus estimates of ($2.45) by $0.24. GRAIL had a negative return on equity of 16.13% and a negative net margin of 243.80%. The business had revenue of $37.53 million during the quarter, compared to analysts' expectations of $44.21 million. Sell-side analysts anticipate that GRAIL will post -9.11 earnings per share for the current fiscal year.
Insider Transactions at GRAIL
In other GRAIL news, CFO Aaron Freidin sold 23,619 shares of the firm's stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $146.39, for a total transaction of $3,457,585.41. Following the transaction, the chief financial officer owned 225,364 shares of the company's stock, valued at approximately $32,991,035.96. This trade represents a 9.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Andrew Partridge sold 7,873 shares of the company's stock in a transaction on Monday, October 5th. The shares were sold at an average price of $146.39, for a total value of $1,152,528.47. Following the completion of the transaction, the insider directly owned 155,865 shares in the company, valued at $22,817,077.35. This represents a 4.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 132,944 shares of company stock worth $15,155,665. 1.83% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in GRAL. North Star Investment Management Corp. increased its stake in shares of GRAIL by 809.1% in the 3rd quarter. North Star Investment Management Corp. now owns 300 shares of the company's stock valued at $42,000 after buying an additional 267 shares during the period. Root Financial Partners LLC bought a new stake in shares of GRAIL in the third quarter valued at approximately $44,000. SBI Securities Co. Ltd. increased its stake in GRAIL by 110.9% in the third quarter. SBI Securities Co. Ltd. now owns 388 shares of the company's stock valued at $54,000 after acquiring an additional 204 shares during the last quarter. Fifth Third Bancorp lifted its holdings in shares of GRAIL by 15,733.3% in the first quarter. Fifth Third Bancorp now owns 475 shares of the company's stock worth $25,000 after acquiring an additional 472 shares during the last quarter. Finally, Allworth Financial LP acquired a new stake in shares of GRAIL during the second quarter valued at about $35,000.
About GRAIL
(
Get Free Report)
GRAIL, Inc. is a healthcare company developing blood-based tests for the early detection of multiple cancers. Its approach analyzes patterns in cell-free DNA, including DNA methylation signals, to help identify a possible cancer signal and predict its origin in the body. GRAIL's flagship product is Galleri, a multi-cancer early detection test intended for use alongside—not as a replacement for—recommended cancer screening. The company also conducts clinical research to evaluate the test and advance its early-detection technology.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GRAIL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GRAIL wasn't on the list.
While GRAIL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.